๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells

โœ Scribed by Sung-Tsai Yu; Tzer-Ming Chen; Shih-Yun Tseng; Yen-Hui Chen

Book ID
116294885
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
284 KB
Volume
358
Category
Article
ISSN
0006-291X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Reversal of doxorubicin resistance in br
Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization
โœ Pei-Jen Lou; Ping-Shan Lai; Ming-Jium Shieh; Alexander J. MacRobert; Kristian Be ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 291 KB

## Abstract Multiple drug resistance (MDR) is a problem that seriously reduces the efficacy of many chemotherapy agents. One mechanism for MDR is increased acidification of endocytic vesicles and increased cytosol pH, so weak base chemotherapeutic agents, including doxorubicin, are trapped in endoc

Lack of modulation of MDR1 gene expressi
Lack of modulation of MDR1 gene expression by dominant inhibition of cAMP-dependent protein kinase in doxorubicin-resistant mcf-7 breast cancer cells
โœ Amadeo M. Parissenti; Brian R. Gannon; David J. Villeneuve; Angela F. Kirwan-rhu ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 172 KB ๐Ÿ‘ 2 views

The drug transporter P-glycoprotein (P-gp) appears to play an important role in the ability of tumor cells to evade killing by chemotherapeutic agents. Using pharmacological inhibitors of cAMP-dependent protein kinase (PKA), it has been suggested that, similar to rodent model systems, the human P-gp